InvestorsHub Logo
Followers 24
Posts 2696
Boards Moderated 0
Alias Born 04/21/2012

Re: None

Tuesday, 09/03/2013 10:45:29 AM

Tuesday, September 03, 2013 10:45:29 AM

Post# of 130507
Dr. Bier will be working closely with Dr. Adam Simon, current member of the Company's Corporate Advisory Board, to finalize and implement the Company's commercialization strategy for LymPro to both maximize potential revenue and position LymPro as a potential companion diagnostic for therapeutic Alzheimer's programs.